Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection
Completed · Phase 2
Conditions studied: Hepatitis C Virus Infection
In brief
This primary objectives of the study are to evaluate the safety, tolerability, and efficacy of voxilaprevir (VOX) plus sofosbuvir/velpatasvir (SOF/VEL) fixed dose combination (FDC) ± ribavirin (RBV) in adults with chronic genotype 1 hepatitis C virus (HCV) infection.
Key facts
- Study ID
- NCT02378935
- Run by
- Gilead Sciences
- People needed
- 205
- Starts
- 2015-02-17
- Expected to finish
- 2016-04-12
- Last updated by the study team
- 2020-03-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Cedars Sinai Medical Center — Los Angeles, California, United States
- Stanford University — Palo Alto, California, United States
- Huntington Memorial Hospital Liver Center — Pasadena, California, United States
- Medical Associates Research Group, Inc. — San Diego, California, United States
- University of Colorado — Denver, Colorado, United States
- Borland-Groover Clinic — Jacksonville, Florida, United States
- University of Miami — Miami, Florida, United States
- Orlando Immunology center — Orlando, Florida, United States
- South Florida Center of Gastroenterology, P.A. — Wellington, Florida, United States
- Center for Hep C/Atlanta Medical Center — Atlanta, Georgia, United States
- Gastrointestinal Specialists of Georgia, PC — Marietta, Georgia, United States
- University of Chicago — Chicago, Illinois, United States
- Indiana University — Indianapolis, Indiana, United States
- Indianapolis Gastroenterology & Hepatology, Inc. — Indianapolis, Indiana, United States
- Beth Isreal Deconess Medical Center — Boston, Massachusetts, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Henry Ford Hospital and Health System — Detroit, Michigan, United States
- ID Care — Hillsborough, New Jersey, United States
- Southwest Care Center — Santa Fe, New Mexico, United States
- North Shore/Long Island Jewish PRIME — Manhasset, New York, United States
- Mount Sinai Beth Israel — New York, New York, United States
- Cumberland Research Associates, LLC — Fayetteville, North Carolina, United States
- Digestive Health Specialists, PA — Winston-Salem, North Carolina, United States
- University of Pennsylvania Health Systems — Philadelphia, Pennsylvania, United States
- UPMC Center for Liver Diseases — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.